- Home
- / Flex Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Flex Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.6
2019-07-19
Market Capitalization
$11 M
2019-07-19
Revenue
$1.8 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 23, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0M | 1.3M | 838.1K | 3.5M | 5.2M | 1.8M | ||
| Cost of goods sold | 662.7K | 506.5K | 430.8K | |||||
| Gross profit | 347.9K | 768.0K | 407.4K | |||||
| Gross profit margin, % | 34.4% | 60.3% | 48.6% | |||||
| General and administrative expense | 4.0M | 16.5M | 19.9M | 18.5M | 10.6M | 7.7M | 6.1M | 6.1M |
| Operating expense total | 8.0M | 29.2M | 40.2M | 35.5M | 22.5M | |||
| EBIT | (39.9M) | (34.7M) | (22.1M) | (8.3M) | (7.8M) | (12.8M) | ||
| EBIT margin, % | -3946.5% | -2724.6% | -2633.7% | |||||
| Interest income | 18.9K | 72.0K | 393.1K | 292.0K | 152.0K | 178.6K | ||
| Interest expense | 15.6K | (3.0K) | ||||||
| Pre tax profit | (8.0M) | (29.2M) | ||||||
| Net Income | (8.0M) | (29.1M) | (39.5M) | (34.4M) | (21.9M) | (6.9M) | (7.4M) | (12.8M) |